Correlation Between ABL Bio and Pharma Reaserch

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABL Bio and Pharma Reaserch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABL Bio and Pharma Reaserch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABL Bio and Pharma Reaserch Prod, you can compare the effects of market volatilities on ABL Bio and Pharma Reaserch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABL Bio with a short position of Pharma Reaserch. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABL Bio and Pharma Reaserch.

Diversification Opportunities for ABL Bio and Pharma Reaserch

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between ABL and Pharma is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding ABL Bio and Pharma Reaserch Prod in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Reaserch Prod and ABL Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABL Bio are associated (or correlated) with Pharma Reaserch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Reaserch Prod has no effect on the direction of ABL Bio i.e., ABL Bio and Pharma Reaserch go up and down completely randomly.

Pair Corralation between ABL Bio and Pharma Reaserch

Assuming the 90 days trading horizon ABL Bio is expected to generate 1.31 times less return on investment than Pharma Reaserch. In addition to that, ABL Bio is 1.42 times more volatile than Pharma Reaserch Prod. It trades about 0.09 of its total potential returns per unit of risk. Pharma Reaserch Prod is currently generating about 0.17 per unit of volatility. If you would invest  23,150,000  in Pharma Reaserch Prod on October 13, 2024 and sell it today you would earn a total of  1,950,000  from holding Pharma Reaserch Prod or generate 8.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

ABL Bio  vs.  Pharma Reaserch Prod

 Performance 
       Timeline  
ABL Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABL Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Pharma Reaserch Prod 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Reaserch Prod are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Pharma Reaserch sustained solid returns over the last few months and may actually be approaching a breakup point.

ABL Bio and Pharma Reaserch Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABL Bio and Pharma Reaserch

The main advantage of trading using opposite ABL Bio and Pharma Reaserch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABL Bio position performs unexpectedly, Pharma Reaserch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Reaserch will offset losses from the drop in Pharma Reaserch's long position.
The idea behind ABL Bio and Pharma Reaserch Prod pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like